Angela Steel

ANGELA STEEL is vice president of clinical operations for infectious diseases at GlaxoSmithKline Pharmaceuticals.  She came to the USA in 1995 to complete a postdoc at Brigham & Women’s hospital and then she joined GlaxoSmithKline in 1998 and has held numerous positions of increasing responsibility within the research and development organization, including antibacterial discovery research, project management and clinical roles.  In 2011 she became the head of the global clinical science and operations supporting Phase II-IV clinical studies for infectious diseases and her team supported the successful file and approval of key HIV medicines.  In recent years she has held an early development lead role on a development collaboration with a US government agency and in 2016 led the clinical team on the integration of HIV assets into GSK.  She is an active coach and mentor at GSK and is an established process improvement practitioner.  She has also led numerous sessions on resilience and energy, change management and is actively pursuing creditation as a Strengths Finder facilitatior. Steel earned her BSc in microbiology from the University of Glasgow, Scotland and her biochemistry PhD at the University of Cambridge, England.  @gsk